SEC Form 4 · accession 0001232524-16-000360
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Treacy
Officer — SVP, Technical Operations
Period of report
Aug 16, 2016
Accepted (ET)
Aug 18, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 16, 2016 | S | 1,287 | $137.468 | D | 13,875 | D | |
| Ordinary Shares | Aug 16, 2016 | S | 5 | $137.46 | D | 13,870 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- F2Includes 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2016.